Trans-generational epistasis between Dnd1Ter and other modifier genes controls susceptibility to testicular germ cell tumors

Human Molecular Genetics

Volumn 16, Issue 18, 2007, Pages 2233-2240

  Lam, Man Yee J ^a   Heaney, Jason D ^a   Youngren, Kirsten K ^a   Kawasoe, Jean H ^a   Nadeau, Joseph H ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI PROTEIN; DND1 PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN DERIVATIVE; PROTEIN P53; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILATERAL CANCER; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; EPIGENETICS; EPISTASIS; FREQUENCY ANALYSIS; GENE INTERACTION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GERM CELL TUMOR; GERM LINE; INHERITANCE; MALE; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; TESTIS TUMOR; VERTICAL TRANSMISSION;

ANIMALS; DISEASE MODELS, ANIMAL; EPISTASIS, GENETIC; FEMALE; GENES, NEOPLASM; GENETIC PREDISPOSITION TO DISEASE; MALE; MICE; MICE, TRANSGENIC; MUTATION; NEOPLASM PROTEINS; NEOPLASMS, GERM CELL AND EMBRYONAL; TESTICULAR NEOPLASMS;

EID: 34548423163     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddm175     Document Type: Article

References (51)

1. Buetow, S. (1995) Epidemiology of testicular cancer. Epidemiol. Rev. 17, 433-449.
2. Horwich, A., Shipley, J. and Huddart, R. (2006) Testicular germ-cell cancer. Lancet, 367, 754-765.
3. Boisen, K.A., Main, K.M., Rajpert-De Meyts, E. and Skakkebaek, N.E. (2001) Are male reproductive disorders a common entity? The testicular dysgenesis syndrome. Ann. N.Y. Acad. Sci., 948, 90-99.
4. Skakkebaek, N.E., Rajpert-De Meyts, E. and Main, K.M. (2001) esticular dysgenesis syndrome: An increasingly common developmental disorder with environmental aspects. Hum. Reprod., 16, 972-978.
5. Safe, S. (2005) Clinical correlates of environmental endocrine disrutors. Trends Endocrinol. Metab., 16, 139-144.
6. Storgaard, L., Bonde, J.P. and Olsen, J. (2006) Male reproductive disorders in humans and prenatal indicators of estrogen exposure. A review of published epidemiological studies. Reprod. Toxicol., 21, 4-15.
7. Lindelhof, B. and Eklund, G. (2001) Analysis of hereditary component of cancer by use of a familial index by site. Lancet, 358, 1696-1698.
8. Forman, D., Oliver, R.T., Brett, A.R., Marsh, S.G., Moses, J.H. Bodmer, J.G., Chilvers, C.E. and Pike, M.C. (1992) Familial testicular cancer: A report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis. Br. J. Cancer, 65, 255-262.
9. Hemminki, K. and Chen, B. (2006) Familial risks in testicular cancer as aetiological clues. Int. J. Androl., 29, 205-210.
10. Crockford, G.P., Linger, R., Hockley, S., Dudakia, D., Johnson, L., Huddart, R., Tucker, K., Friedlander, M., Philips, K.A. and Hogg, D. (2006) Genome-wide linkage screen for testicular germ cell tumour susceptibility loci. Hum. Mol. Genet., 15, 443-451.
11. Nathanson, K.L., Kanetsky, P.A., Hawes, R., Vaughn, D.J. and Letrero, R. (2005) The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am. J. Hum. Genet., 77, 1034-1043.
12. Stevens, L.C. and Hummel, K.P. (1957) A description of spontaneous congenital testicular teratomas in strain 129 mice. J. Natl. Cancer Inst., 18, 719-731.
13. Stevens, L.C. (1967) The biology of teratomas. Adv. Morphog, 6 1-31.
14. Matin, A. and Nadeau, J.H. (2001) Sensitized polygenic trait analysis. Trends Genet., 17, 727-731.
15. Collin, G.B., Asada, Y., Varnum, D.S. and Nadeau, J.H. (1996) DNA pooling as a quick method for finding candidate linkages in multigenic trait analysis: An example involving susceptibility to germ cell tumors. Mamm. Genome, 7, 68-70.
16. Muller, A.J., Teresky, A.K. and Levene, A.J. (2000) A male germ cell tumor-susceptibility-determining locus, pgct1, identified on murine chromosome 13. Proc. Natl. Acad. Sci. USA, 97, 8421-8426.
17. Lam, M.-Y., Youngren, K.K. and Nadeau, J.H. (2004) Enhancers and suppressors of testicular cancer susceptibility in single- and double-mutant mice. Genetics, 166, 925-933.
18. Takabayashi, S., Sasaoka, Y., Yamashita, M., Tokumoto, T., Ishikawa, K. and Noguchi, M. (2001) Novel growth factor supporting survival of murine primordial germ cells: Evidence form conditioned medium of ter fetal gonadal somatic cells. Mol. Reprod. Dev., 60, 384-396.
19. Noguchi, T. and Noguchi, M. (1985) A recessive mutation (ter) causing germ cell deficiency and a high incidence of congenital testicular teratomas in 129/Sv-ter mice. J. Natl. Cancer Inst., 75, 385-392.
20. Huyghe, E., Matsuda, T. and Thonneau, P. (2003) Increasing incidence of testicular cancer worldwide: A review. J. Urol., 170, 5-11.
21. Dieckmann, K.P. and Pichlmeier (2004). Clinical epidemiology of testicular germ cell tumors. World J. Urol., 22, 2-14.
22. Youngren, K.K., Nadeau, J.H. and Matin, A. (2003) Testicular cancer susceptibility in the 129.MOLF-Chr19 mouse strain: Additive effects, gene interactions and epigenetic modifications. Hum. Mol. Genet., 12, 389-398.
23. Seydoux, G. and Braun, R.E. (2006) Pathway to totipotency: Lessons from germ cells. Cell, 127, 891-904.
24. Looijenga, L.H., de Leeuw, H., van Oorschot, M., van Gurp, R.J., Stoop, H. et al. (2003) Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors. Cancer Res., 63, 7674-7678.
25. Jaenisch, R. and Bird, A. (2003) Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals. Nat. Genet., 33, 245-254.
26. Anway, M.D., Cupp, A.S., Uzumcu, M. and Skinner, M.K. (2005) Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science, 308, 1466-1469.
27. Barton, T.S., Robaire, B. and Hales, B.F. (2005) Epigenetic programming in the preimplantation rat embryo is disrupted by chronic paternal cyclophosphamide exposure. Proc. Natl. Acad. Sci. USA, 102, 7865-7870.
28. Cropley, J.E., Suter, C.M., Beckman, K.B. and Martin, D.I., (2006) Germ-line epigenetic modification of the murine A vy allele by nutritional supplementation. Proc. Natl Acad. Sci. USA, 103, 17308-17312.
29. Rakyan, V. and Whitelaw, E. (2003) Transgenerational epigenetic inheritance. Curr. Biol., 13, R6.
30. Mehta, A., Kinter, M.T., Sherman, N.E. and Driscoll, D.M. (2000) Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA. Mol. Cell. Biol., 20, 1846-1854.
31. Heaney, J.D. and Nadeau, J.H. (in press) Testicular germ cell tumors in mice. In Hou, S. (ed.), Germline Stem Cell Protocols. Methods in Molecular Biology, Humana Press, Totowa, NJ.
32. Navaratnam, N. and Sarwar, R. (2006) An overview of cytidine deaminases. Int. J. Hematol., 83, 195-200.
33. Houbavity, H.B., Murray, M.F. and Sharp, P.A. (2003) Embryonic stem cell-specific microRNAs. Dev. Cell, 5, 351-358.
34. Bartel, D.P. (2004) MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell, 116, 281-297.
35. Voorhoeve, P.M., le Sage, S., Schrier, M., Gillis, A.J.M., Stoop, H. et al. (2006) A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell, 124, 1169-1181.
36. Matin, A., Collin, G.B., Asada, Y., Varnum, D. and Nadeau, J.H. (1999) Susceptibility to testicular germ-cell tumours in a 129.MOLF-Chr 19 chromosome substitution strain. Nat. Genet, 23, 237-240.
37. Youngren, K.K., Coveney, D., Peng, X., Bhattacharya, C., Schmidt, L.S. et al. (2005) The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours. Nature, 435, 360-364.
38. Silver, W.K. (1979) The Coat Colors of Mice. Springer-Verlag, New York.
39. Stevens, L.C. (1973) A new inbred subline of mice (129-terSv) with a high incidence of spontaneous congenital testicular teratomas. J. Natl. Cancer Inst, 50, 235-242.
40. Rapley, E.A., Hockley, S., Warren, W., Johnson, L., Huddart R. et al. (2004) Somatic mutations of KIT in familial testicular germ cell tumours. Br. J. Cancer, 90, 2397-2401.
41. Malkin, D. (1998) The Li-Fraumeni syndrome. In Vogelstein, B. and Kinzler, K.W. (eds), The Genetic Basis of Human Cancer. McGraw-Hill, New York, pp. 393-407.
42. Guran, S., Tunca, Y. and Imirzalioglu, N. (1999) Hereditary TP53 codon 292 and somatic P16INK4A codon 94 mutations in a Li-Fraumeni syndrome family. Cancer Genet. Cytogenet., 113, 145-151.
43. Malkin, D., Li, F.P., Strong, L.C., Fraumeni, J.F., Nelson, C.E., Kim, D.H., et al. (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science, 250 1233-1238.
44. Donehower, L.A., Harvey, M., Slagle, B.L. and McArthur, M.J. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature, 356, 215-221.
45. Harvey, M., McArthur, M.J., Montgomery, C.A., Bradley, A. and Donohower, L.A. (1993) Genetic background alters the spectrum of tumors that develop in p53- deficient mice. FASEB J, 7, 938-943.
46. Donehower, L.A., Harvey, M., Vogel, H., McArthur, M.J. and Montgomery, C.A. (1995) Effects of genetic background on tumorigenesis in p53-deficient mice. Mol. Carcinog, 14, 16-22.
47. Vlahakis, G. and Heston, W.E. (1963) J. Natl. Cancer Inst., 31 189-195.
48. Michaud, E.J., Bultman, S.J., Klebig, M.L., van Vugt, M.J., Stubbs, L.J., Russell, L.B. and Woychik, R.P. A molecular model for the gentic and phenotypic characterisctics of the mouse lethal yellow (Ay) mutation. Proc. Natl Acad. Sci. USA, 91, 2562-2566.
49. Khrebtukova, I., Kuklin, A., Woychik, R.P. and Michaud, E.J. (1999) Alternative processing of the human and mouse raly genes. Biochim. Biophys. Acta, 1447, 107-112.
50. Gidekel, S., Pizov, G., Bergman, Y. and Pikarsky, E. (2003) Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell, 4, 361-370.
51. Di Cristofano, A., Peace, B., Cordon-Cardo, C. and Pandolfi, P.P. (1998) Pten is essential for embryonic development and tumour suppression. Nat. Genet., 19, 348-355.